NM_019080.3:c.250C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019080.3(NDFIP2):c.250C>T(p.Leu84Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000134 in 1,562,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_019080.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDFIP2 | NM_019080.3 | c.250C>T | p.Leu84Phe | missense_variant | Exon 1 of 8 | ENST00000218652.12 | NP_061953.2 | |
NDFIP2 | NM_001394685.1 | c.250C>T | p.Leu84Phe | missense_variant | Exon 1 of 8 | NP_001381614.1 | ||
NDFIP2 | NM_001161407.2 | c.250C>T | p.Leu84Phe | missense_variant | Exon 1 of 8 | NP_001154879.1 | ||
NDFIP2-AS1 | NR_046685.1 | n.-222G>A | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000301 AC: 5AN: 166118Hom.: 0 AF XY: 0.0000451 AC XY: 4AN XY: 88786
GnomAD4 exome AF: 0.0000135 AC: 19AN: 1410678Hom.: 0 Cov.: 31 AF XY: 0.0000158 AC XY: 11AN XY: 696784
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.250C>T (p.L84F) alteration is located in exon 1 (coding exon 1) of the NDFIP2 gene. This alteration results from a C to T substitution at nucleotide position 250, causing the leucine (L) at amino acid position 84 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at